Hypertension, Vol 23, 613-618, Copyright © 1994 by American Heart Association
TL Stevens, CM Wei, LL Aahrus, DM Heublein, M Kinoshita, Y Matsuda and JC Burnett Jr
Atrial natriuretic peptide is an important peptide hormone of cardiac
origin that functions to regulate cardiac preload via the regulation of
sodium excretion. This natriuretic action occurs through activation of the
particulate guanylyl cyclase-linked natriuretic peptide-A receptor.
HS-142-1 is a newly discovered antagonist of the natriuretic peptide-A
receptor that permits insight into the functional role of atrial
natriuretic peptide in cardiorenal homeostasis. The first objective of this
study was to define for the first time the intrarenal action of HS- 142-1
on exogenous atrial natriuretic peptide-mediated natriuresis in
anesthetized normal dogs. In group 1 (n = 6), which received intravenous
atrial natriuretic peptide at 100 ng/kg per minute, intrarenal HS-142-1
(0.5 mg/kg bolus) attenuated atrial natriuretic peptide-induced increases
in glomerular filtration rate, urine flow, sodium excretion, and renal
cyclic GMP generation and decreases in distal tubular sodium reabsorption.
The second objective was to determine whether endogenous atrial natriuretic
peptide participates in the regulation of basal sodium excretion. In group
2 (n = 6), intrarenal HS-142-1 alone decreased both absolute and fractional
sodium excretion and renal cyclic GMP generation and increased distal
tubular sodium reabsorption. These studies demonstrate that HS-142-1
markedly attenuates exogenous atrial natriuretic peptide-mediated
natriuresis via enhancement of distal tubular reabsorption and blunting of
increases in glomerular filtration rate. Second, the current studies
support a functional role for endogenous atrial natriuretic peptide in the
regulation of basal sodium excretion.
ARTICLES
Modulation of exogenous and endogenous atrial natriuretic peptide by a receptor inhibitor
Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minn 55905.
This article has been cited by other articles:
![]() |
F. L. Martin, T. Supaporn, H. H. Chen, S. M. Sandberg, Y. Matsuda, M. Jougasaki, and J. C. Burnett Jr. Distinct roles for renal particulate and soluble guanylyl cyclases in preserving renal function in experimental acute heart failure Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1580 - R1585. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Boomsma and A. H. van den Meiracker Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use Cardiovasc Res, August 15, 2001; 51(3): 442 - 449. [Full Text] [PDF] |
||||
![]() |
O. Lisy, M. M. Redfield, S. Jovanovic, M. Jougasaki, A. Jovanovic, H. Leskinen, A. Terzic, and J. C. Burnett Jr Mechanical Unloading Versus Neurohumoral Stimulation on Myocardial Structure and Endocrine Function In Vivo Circulation, July 18, 2000; 102(3): 338 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. WILLENBROCK, I. PAGEL, M. SCHEUERMANN, K. HÖHNEL, H. S. MACKENZIE, B. M. BRENNER, and R. DIETZ Renal Function in High-Output Heart Failure in Rats: Role ofEndogenous Natriuretic Peptides J. Am. Soc. Nephrol., March 1, 1999; 10(3): 572 - 580. [Abstract] [Full Text] |
||||
![]() |
K. Yamamoto, J. C. Burnett Jr., and M. M. Redfield Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2406 - H2414. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gunning, R. J. Solomon, F. H. Epstein, and P. Silva Role of guanylyl cyclase receptors for CNP in salt secretion by shark rectal gland Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1997; 273(4): R1400 - R1406. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Marttila, O. Vuolteenaho, D. Ganten, K. Nakao, and H. Ruskoaho Synthesis and Secretion of Natriuretic Peptides in the Hypertensive TGR(mREN-2)27 Transgenic Rat Hypertension, December 1, 1996; 28(6): 995 - 1004. [Abstract] [Full Text] |
||||
![]() |
J. G. Drewett, B. M. Fendly, D. L. Garbers, and D. G. Lowe Natriuretic Peptide Receptor-B (Guanylyl Cyclase-B) Mediates C-type Natriuretic Peptide Relaxation of Precontracted Rat Aorta J. Biol. Chem., March 3, 1995; 270(9): 4668 - 4674. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |